Samuel E DePrimo

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification

D. Khatry, J. Cherrington, Samuel E DePrimo, 2003, BMC Cancer.

Transcriptional programs activated by exposure of human prostate cancer cells to androgen

Robert Tibshirani, Maximilian Diehn, James D Brooks, 2002, Genome Biology.

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

H. Rugo, A. Wolff, H. Burstein, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

John Smeraglia, R. Motzer, M. Michaelson, 2007, Journal of Translational Medicine.

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.

R. Figlin, R. Motzer, M. Michaelson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.